“Bimekizumab Efficacy in Patients With Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 Years of Treatment in 5 Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s308, https://doi.org/10.25251/skin.8.supp.308.